Abstract:The final, formatted version of the article will be published soon. You have multiple emails registered with Frontiers: Please enter your email address: If you already have an account, please login You don't have a Frontiers account ? You can register here Tuberculosis (TB) has once again become the world's leading cause of death from a single infectious agent following three years of COVID19 pandemic [1]. Accounting for 1.25 million deaths, TB remains the leading cause of death among people living with human immunodeficiency virus (HIV) (PLWH) [1], and was responsible for approximately twice as many deaths as HIV/ acquired immunodeficiency syndrome (AIDS) alone [2]. The immune responses to monoinfection with the causative agent, Mycobacterium tuberculosis (Mtb), are distinct from those observed in individuals infected with HIV or in those who are coinfected with both pathogens [3,4]. Pulmonary TB represents the most common manifestation of the active disease, characterized by the presence of classical lung caseous/necrotic granuloma lesions, accompanied by exudation. The disease typically progresses after two years of a latent TB infection, an asymptomatic immune activated phase following the initial primary infection [1,5].The immune cells involved in the responses to Mtb infection include innate myeloid cells, such as macrophages and neutrophils, and adaptive lymphocytes including T and B cells. If the equilibrium between innate and adaptive immune cells, which is essential for maintaining an appropriate proinflammatory/anti-inflammatory cytokine milieu, is disrupted, Mtb may disseminate from lungs to other organs, leading to the development of extrapulmonary TB. An appropriate adaptive response is necessary to facilitate the homing of effector T-lymphocytes, which is essential for the full organization and sustainability of the granuloma. This means that mycobacteria-containing macrophages are situated at the center, encircled by a rim of newly arrived lymphocytes that form a solid granuloma and exhibit a highly organized framework with high vascularization [6]. A failure to maintain this dynamic will result in structural disruption, thereby facilitating the migration of infected macrophages to other organs [7].It has long been established that functional impairments in both the innate and adaptive immune responses in PLWH contribute to an increased risk of TB disease in this population [8]. As a consequence of the immunodeficiency status generated by low CD4 + T-cell counts, this population is also more prone to the development of independent or concurrent extrapulmonary TB. Consequently, the pathophysiology of Mtb infection differs in HIV-positive individuals, and even more so in those who have progressed to severe AIDS phase. The mechanisms by which alterations in Mtb-specific T-cell responses may impede the early clearance of Mtb or sustained control of LTBI in PLWH remain poorly understood. PLWH appear to an altered cytokine profile in response to Mtb, which includes impairments in type I helper T-cell responses (Th1), a reduction in the activity of Th17 cells and regulatory T-cells, and an increase in immunosuppressive cytokines [8,9]. Furthermore, the incidence of smear-negative and subclinical TB is also higher among co-infected patients. This results in a reduction of the sensitivity of screening tests based on sputum examination.The identification of immune-related complexes or molecules that can be defined as diagnostic markers for Mtb in PLWH may facilitate the development of new diagnostic tools and the exploration of new therapeutic approaches. In comparison to monoinfections with either HIV or Mtb, during coinfection the immune cells subsets and functions in the peripheral blood, as well as their redistribution in local lesions, may undergo dramatic alterations. Additionally, deviations in the metabolism and the divergence of the ubiquitin machinery may also be observed. Altogether, the aforementioned factors represent the focus of this research topic.In this issue, an original research article by Yandrapally et al. (https://doi.org/10.3389/fimmu.2023.1276817) shows that the Mtb-secreted transcription regulator EspR contributes to a syndemic interaction during coinfection with HIV. It is hypothesized that binding to the putative cognate motif on the promoter region of the host IL-4 gene, leads to IL-4 gene expression, causing high IL-4 titers that induce a Th2-type microenvironment. Consequently, this results in a shift towards a Th2-type response, which facilitates macrophage polarization to a M2 anti-inflammatory and metabolic status that favours Mtb persistence. Chronic infection by HIV tends to induce a shift in the viral population from the R5 to the X4 phenotype, which is accompanied by an increasing in the expression of the CXCR4 receptor. This suggests that the mycobacteria-induced selection of X4 -Abstract Truncated-

Alveolar macrophages from persons living with HIV show impaired epigenetic response to Mycobacterium tuberculosis

HIV infection impairs the host response to Mycobacterium tuberculosis infection by altering surfactant protein D function in the human lung alveolar mucosa

Increased Microbial Translocation is a Prognostic Biomarker of Different Immune Responses to ART in People Living with HIV

Potential role of alveolar macrophages in HIV persistence and lung disease

[Potential role of alveolar macrophages in HIV persistence and lung disease]

The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis

Correlation of Oral Microbiota with Different Immune Responses to Antiretroviral Therapy in People Living with HIV

Editorial: Immune responses to MTB infection in people living with HIV

Effect of HIV status on Th17/IL-17 immune function in subjects undergoing tuberculosis treatment in Kenya

infection associated immune perturbations correlate with antiretroviral immunity

Mycobacterium tuberculosis -induced monocyte transcriptional responses associated with resistance to tuberculin skin test/interferon-γ release assay conversion in people with HIV

Contrasting Inflammatory Signatures in Peripheral Blood and Bronchoalveolar Cells Reveal Compartment-Specific Effects of HIV Infection

Monocyte activation in persons living with HIV and tuberculosis coinfection

Airway Aging and Methylation Disruptions in HIV-associated Chronic Obstructive Pulmonary Disease

Dynamics of pulmonary mucosal cytotoxic CD8 T-cells in people living with HIV under suppressive antiretroviral therapy

Effect of Advanced HIV Infection on the Respiratory Microbiome

Transcriptional Profiling of Mycobacterium Tuberculosis Replicating Ex Vivo in Blood from HIV- and HIV+ Subjects.

Uncovering the Bronchoalveolar Single-Cell Landscape of Patients With Pulmonary Tuberculosis With Human Immunodeficiency Virus Type 1 Coinfection

Immunoregulatory molecule expression on extracellular microvesicles in people living with HIV

DNA Methylation Demonstrates Bronchoalveolar Cell Senescence in People Living with HIV: An Observational Cohort Study

Exposure to Mycobacterium remodels alveolar macrophages and the early innate response to Mycobacterium tuberculosis infection